Sedation In ICU Setting Market, Global Outlook and Forecast 2022-2028

March 2022 | 65 pages | ID: S2C20061C3D4EN
Market Monitor Global

Abstracts

Sedation is the reduction of irritability or agitation by administration of sedative drugs, generally to facilitate a medical procedure or diagnostic procedure.

This report contains market size and forecasts of Sedation In ICU Setting in Global, including the following market information:

Global Sedation In ICU Setting Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Sedation In ICU Setting market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Propofol Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Sedation In ICU Setting include AstraZeneca, GlaxoSmithKline, Mylan, Fresenius, Teva, B. Braun Holding and Aspen, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Sedation In ICU Setting companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Sedation In ICU Setting Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Sedation In ICU Setting Market Segment Percentages, by Type, 2021 (%)

• Propofol
• Dexmedetomidine
• Remifentanil
• Others

Global Sedation In ICU Setting Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Sedation In ICU Setting Market Segment Percentages, by Application, 2021 (%)

• Neonatal Intensive Care Unit
• Child Intensive Care Unit
• Adult Intensive Care Unit

Global Sedation In ICU Setting Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Sedation In ICU Setting Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Sedation In ICU Setting revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Sedation In ICU Setting revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• AstraZeneca
• GlaxoSmithKline
• Mylan
• Fresenius
• Teva
• B. Braun Holding
• Aspen

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Sedation In ICU Setting Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Sedation In ICU Setting Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL SEDATION IN ICU SETTING OVERALL MARKET SIZE

2.1 Global Sedation In ICU Setting Market Size: 2021 VS 2028
2.2 Global Sedation In ICU Setting Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Sedation In ICU Setting Players in Global Market
3.2 Top Global Sedation In ICU Setting Companies Ranked by Revenue
3.3 Global Sedation In ICU Setting Revenue by Companies
3.4 Top 3 and Top 5 Sedation In ICU Setting Companies in Global Market, by Revenue in 2021
3.5 Global Companies Sedation In ICU Setting Product Type
3.6 Tier 1, Tier 2 and Tier 3 Sedation In ICU Setting Players in Global Market
  3.6.1 List of Global Tier 1 Sedation In ICU Setting Companies
  3.6.2 List of Global Tier 2 and Tier 3 Sedation In ICU Setting Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Sedation In ICU Setting Market Size Markets, 2021 & 2028
  4.1.2 Propofol
  4.1.3 Dexmedetomidine
  4.1.4 Remifentanil
  4.1.5 Others
4.2 By Type - Global Sedation In ICU Setting Revenue & Forecasts
  4.2.1 By Type - Global Sedation In ICU Setting Revenue, 2017-2022
  4.2.2 By Type - Global Sedation In ICU Setting Revenue, 2023-2028
  4.2.3 By Type - Global Sedation In ICU Setting Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Sedation In ICU Setting Market Size, 2021 & 2028
  5.1.2 Neonatal Intensive Care Unit
  5.1.3 Child Intensive Care Unit
  5.1.4 Adult Intensive Care Unit
5.2 By Application - Global Sedation In ICU Setting Revenue & Forecasts
  5.2.1 By Application - Global Sedation In ICU Setting Revenue, 2017-2022
  5.2.2 By Application - Global Sedation In ICU Setting Revenue, 2023-2028
  5.2.3 By Application - Global Sedation In ICU Setting Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Sedation In ICU Setting Market Size, 2021 & 2028
6.2 By Region - Global Sedation In ICU Setting Revenue & Forecasts
  6.2.1 By Region - Global Sedation In ICU Setting Revenue, 2017-2022
  6.2.2 By Region - Global Sedation In ICU Setting Revenue, 2023-2028
  6.2.3 By Region - Global Sedation In ICU Setting Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Sedation In ICU Setting Revenue, 2017-2028
  6.3.2 US Sedation In ICU Setting Market Size, 2017-2028
  6.3.3 Canada Sedation In ICU Setting Market Size, 2017-2028
  6.3.4 Mexico Sedation In ICU Setting Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Sedation In ICU Setting Revenue, 2017-2028
  6.4.2 Germany Sedation In ICU Setting Market Size, 2017-2028
  6.4.3 France Sedation In ICU Setting Market Size, 2017-2028
  6.4.4 U.K. Sedation In ICU Setting Market Size, 2017-2028
  6.4.5 Italy Sedation In ICU Setting Market Size, 2017-2028
  6.4.6 Russia Sedation In ICU Setting Market Size, 2017-2028
  6.4.7 Nordic Countries Sedation In ICU Setting Market Size, 2017-2028
  6.4.8 Benelux Sedation In ICU Setting Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Sedation In ICU Setting Revenue, 2017-2028
  6.5.2 China Sedation In ICU Setting Market Size, 2017-2028
  6.5.3 Japan Sedation In ICU Setting Market Size, 2017-2028
  6.5.4 South Korea Sedation In ICU Setting Market Size, 2017-2028
  6.5.5 Southeast Asia Sedation In ICU Setting Market Size, 2017-2028
  6.5.6 India Sedation In ICU Setting Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Sedation In ICU Setting Revenue, 2017-2028
  6.6.2 Brazil Sedation In ICU Setting Market Size, 2017-2028
  6.6.3 Argentina Sedation In ICU Setting Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Sedation In ICU Setting Revenue, 2017-2028
  6.7.2 Turkey Sedation In ICU Setting Market Size, 2017-2028
  6.7.3 Israel Sedation In ICU Setting Market Size, 2017-2028
  6.7.4 Saudi Arabia Sedation In ICU Setting Market Size, 2017-2028
  6.7.5 UAE Sedation In ICU Setting Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 AstraZeneca
  7.1.1 AstraZeneca Corporate Summary
  7.1.2 AstraZeneca Business Overview
  7.1.3 AstraZeneca Sedation In ICU Setting Major Product Offerings
  7.1.4 AstraZeneca Sedation In ICU Setting Revenue in Global Market (2017-2022)
  7.1.5 AstraZeneca Key News
7.2 GlaxoSmithKline
  7.2.1 GlaxoSmithKline Corporate Summary
  7.2.2 GlaxoSmithKline Business Overview
  7.2.3 GlaxoSmithKline Sedation In ICU Setting Major Product Offerings
  7.2.4 GlaxoSmithKline Sedation In ICU Setting Revenue in Global Market (2017-2022)
  7.2.5 GlaxoSmithKline Key News
7.3 Mylan
  7.3.1 Mylan Corporate Summary
  7.3.2 Mylan Business Overview
  7.3.3 Mylan Sedation In ICU Setting Major Product Offerings
  7.3.4 Mylan Sedation In ICU Setting Revenue in Global Market (2017-2022)
  7.3.5 Mylan Key News
7.4 Fresenius
  7.4.1 Fresenius Corporate Summary
  7.4.2 Fresenius Business Overview
  7.4.3 Fresenius Sedation In ICU Setting Major Product Offerings
  7.4.4 Fresenius Sedation In ICU Setting Revenue in Global Market (2017-2022)
  7.4.5 Fresenius Key News
7.5 Teva
  7.5.1 Teva Corporate Summary
  7.5.2 Teva Business Overview
  7.5.3 Teva Sedation In ICU Setting Major Product Offerings
  7.5.4 Teva Sedation In ICU Setting Revenue in Global Market (2017-2022)
  7.5.5 Teva Key News
7.6 B. Braun Holding
  7.6.1 B. Braun Holding Corporate Summary
  7.6.2 B. Braun Holding Business Overview
  7.6.3 B. Braun Holding Sedation In ICU Setting Major Product Offerings
  7.6.4 B. Braun Holding Sedation In ICU Setting Revenue in Global Market (2017-2022)
  7.6.5 B. Braun Holding Key News
7.7 Aspen
  7.7.1 Aspen Corporate Summary
  7.7.2 Aspen Business Overview
  7.7.3 Aspen Sedation In ICU Setting Major Product Offerings
  7.7.4 Aspen Sedation In ICU Setting Revenue in Global Market (2017-2022)
  7.7.5 Aspen Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Sedation In ICU Setting Market Opportunities & Trends in Global Market
Table 2. Sedation In ICU Setting Market Drivers in Global Market
Table 3. Sedation In ICU Setting Market Restraints in Global Market
Table 4. Key Players of Sedation In ICU Setting in Global Market
Table 5. Top Sedation In ICU Setting Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Sedation In ICU Setting Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Sedation In ICU Setting Revenue Share by Companies, 2017-2022
Table 8. Global Companies Sedation In ICU Setting Product Type
Table 9. List of Global Tier 1 Sedation In ICU Setting Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Sedation In ICU Setting Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Sedation In ICU Setting Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Sedation In ICU Setting Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Sedation In ICU Setting Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Sedation In ICU Setting Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Sedation In ICU Setting Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Sedation In ICU Setting Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Sedation In ICU Setting Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Sedation In ICU Setting Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Sedation In ICU Setting Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Sedation In ICU Setting Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Sedation In ICU Setting Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Sedation In ICU Setting Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Sedation In ICU Setting Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Sedation In ICU Setting Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Sedation In ICU Setting Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Sedation In ICU Setting Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Sedation In ICU Setting Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Sedation In ICU Setting Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Sedation In ICU Setting Revenue, (US$, Mn), 2023-2028
Table 30. AstraZeneca Corporate Summary
Table 31. AstraZeneca Sedation In ICU Setting Product Offerings
Table 32. AstraZeneca Sedation In ICU Setting Revenue (US$, Mn), (2017-2022)
Table 33. GlaxoSmithKline Corporate Summary
Table 34. GlaxoSmithKline Sedation In ICU Setting Product Offerings
Table 35. GlaxoSmithKline Sedation In ICU Setting Revenue (US$, Mn), (2017-2022)
Table 36. Mylan Corporate Summary
Table 37. Mylan Sedation In ICU Setting Product Offerings
Table 38. Mylan Sedation In ICU Setting Revenue (US$, Mn), (2017-2022)
Table 39. Fresenius Corporate Summary
Table 40. Fresenius Sedation In ICU Setting Product Offerings
Table 41. Fresenius Sedation In ICU Setting Revenue (US$, Mn), (2017-2022)
Table 42. Teva Corporate Summary
Table 43. Teva Sedation In ICU Setting Product Offerings
Table 44. Teva Sedation In ICU Setting Revenue (US$, Mn), (2017-2022)
Table 45. B. Braun Holding Corporate Summary
Table 46. B. Braun Holding Sedation In ICU Setting Product Offerings
Table 47. B. Braun Holding Sedation In ICU Setting Revenue (US$, Mn), (2017-2022)
Table 48. Aspen Corporate Summary
Table 49. Aspen Sedation In ICU Setting Product Offerings
Table 50. Aspen Sedation In ICU Setting Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Sedation In ICU Setting Segment by Type in 2021
Figure 2. Sedation In ICU Setting Segment by Application in 2021
Figure 3. Global Sedation In ICU Setting Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Sedation In ICU Setting Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Sedation In ICU Setting Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Sedation In ICU Setting Revenue in 2021
Figure 8. By Type - Global Sedation In ICU Setting Revenue Market Share, 2017-2028
Figure 9. By Application - Global Sedation In ICU Setting Revenue Market Share, 2017-2028
Figure 10. By Region - Global Sedation In ICU Setting Revenue Market Share, 2017-2028
Figure 11. By Country - North America Sedation In ICU Setting Revenue Market Share, 2017-2028
Figure 12. US Sedation In ICU Setting Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Sedation In ICU Setting Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Sedation In ICU Setting Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Sedation In ICU Setting Revenue Market Share, 2017-2028
Figure 16. Germany Sedation In ICU Setting Revenue, (US$, Mn), 2017-2028
Figure 17. France Sedation In ICU Setting Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Sedation In ICU Setting Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Sedation In ICU Setting Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Sedation In ICU Setting Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Sedation In ICU Setting Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Sedation In ICU Setting Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Sedation In ICU Setting Revenue Market Share, 2017-2028
Figure 24. China Sedation In ICU Setting Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Sedation In ICU Setting Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Sedation In ICU Setting Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Sedation In ICU Setting Revenue, (US$, Mn), 2017-2028
Figure 28. India Sedation In ICU Setting Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Sedation In ICU Setting Revenue Market Share, 2017-2028
Figure 30. Brazil Sedation In ICU Setting Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Sedation In ICU Setting Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Sedation In ICU Setting Revenue Market Share, 2017-2028
Figure 33. Turkey Sedation In ICU Setting Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Sedation In ICU Setting Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Sedation In ICU Setting Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Sedation In ICU Setting Revenue, (US$, Mn), 2017-2028
Figure 37. AstraZeneca Sedation In ICU Setting Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. GlaxoSmithKline Sedation In ICU Setting Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Mylan Sedation In ICU Setting Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Fresenius Sedation In ICU Setting Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Teva Sedation In ICU Setting Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. B. Braun Holding Sedation In ICU Setting Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Aspen Sedation In ICU Setting Revenue Year Over Year Growth (US$, Mn) & (2017-2022)